This activity is intended for hematologists, pediatricians, primary care physicians, nurses, and nurse practitioners. It is part of Medscape’s series “Clinical Advances in Gene Therapy for Hemophilia.” Presented through a collaboration between Medscape and the National Hemophilia Foundation, the series includes various discussions relevant to the latest data on gene therapy as well as the practicalities associated with using gene therapy for hemophilia.
The goal is to prepare providers for real-world considerations with regard to successfully incorporating gene therapy into clinical practice.
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- Practical considerations for incorporating gene therapy into care, should it become available
- Have greater competence related to
- Identifying patients who may be candidates for gene therapy, should it become available
- Demonstrate greater confidence in their ability to
- Engage with the interprofessional care team to best administer gene therapy, as appropriate
From Principles to Practice: Preparing for the Advent of Gene Therapy
Authors: Steven Pipe, MD; Andrew Leavitt, MD
CME / ABIM MOC / CE Released: 1/11/2021
Valid for credit through: 1/11/2022
If you are already registered with Medscape follow this link to “From Principles to Practice: Preparing for the Advent of Gene Therapy.”
Access this link to visit the “Clinical Advances in Gene Therapy for Hemophilia” homepage.
If you are not already registered, go to Medscape.org where registration is straightforward and free of charge.
This activity is supported by an independent education grant from uniQure, BioMarin, and Spark Therapeutics.